登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，3月3日，Open peer-review platform for COVID-19 preprints》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-04

  • The public call for rapid sharing of research data relevant to the COVID-19 outbreak (see go.nature.com/2t1lyp6) is driving an unprecedented surge in (unrefereed) preprints. To help pinpoint the most important research, we have launched Outbreak Science Rapid PREreview, with support from the London-based charity Wellcome. This is an open-source platform for rapid review of preprints related to emerging outbreaks (see https://outbreaksci.prereview.org).

  • 原文来源：https://www.nature.com/articles/d41586-020-00613-4
30浏览量
原文链接
相关报告

  • 《Lancet，3月24日，Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-25
    • Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility Maimuna S Majumder Kenneth D Mandl Open AccessPublished:March 24, 2020DOI:https://doi.org/10.1016/S2214-109X(20)30113-3 Since it was first reported by WHO in Jan 5, 2020, over 80?000 cases of a novel coronavirus disease (COVID-19) have been diagnosed in China, with exportation events to nearly 90 countries, as of March 6, 2020.1 Given the novelty of the causative pathogen (named SARS-CoV-2), scientists have rushed to fill epidemiological, virological, and clinical knowledge gaps—resulting in over 50 new studies about the virus between January 10 and January 30 alone.2 However, in an era where the immediacy of information has become an expectation of decision makers and the general public alike, many of these studies have been shared first in the form of preprint papers—before peer review.
    207浏览量
    原文链接

  • 《Nature，3月19日，Functional exhaustion of antiviral lymphocytes in COVID-19 patients》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-20
    • Functional exhaustion of antiviral lymphocytes in COVID-19 patients Meijuan Zheng, Yong Gao, Gang Wang, Guobin Song, Siyu Liu, Dandan Sun, Yuanhong Xu & Zhigang Tian Cellular & Molecular Immunology (2020) In December 2019, a novel coronavirus was first reported in Wuhan, China.1 It was named by the World Health Organization as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is responsible for coronavirus disease 2019 (COVID-19). Up to 28 February 2020, 79,394 cases have been confirmed according to China’s National Health Commission. Outside China, the virus has spread rapidly to over 36 countries and territories.
    109浏览量
    原文链接